Alimta (pemetrexed disodium) NDC 0002-7623

NDC codes

FDA NDC Directory

Product NDC (as listed)0002-7623Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00002-7623Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0002-7623-01	00002762301	1 VIAL in 1 CARTON (0002-7623-01) / 20 mL in 1 VIALMarketed from Feb 13, 2004

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Alimta
Generic name (nonproprietary): pemetrexed disodium
Active ingredients: Pemetrexed disodium heptahydrate — 500 mg/20mL
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: Eli Lilly and Company
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 021462
Marketing start: Feb 4, 2004
Listing expires: Dec 31, 2026
Other FDA classes: Folic Acid Metabolism Inhibitors (Mechanism)
Identifiers: Product ID 0002-7623_3af0bc84-13d6-46aa-a4c0-c62410b73bc6SPL ID 3af0bc84-13d6-46aa-a4c0-c62410b73bc6SPL set ID f5a860f3-37ec-429c-ae04-9c88d7c55c08RxCUI 1728072, 1728075, 1728077, 1728079UNII 9T47E4OM16
Pharmacologic class: Folate Analog Metabolic Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400002762301 followed by a unit qualifier and the quantity

Package 00002-7623-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 19, 2023.

Indications (excerpt from the label)

ALIMTA ® is a folate analog metabolic inhibitor indicated: in combination with pembrolizumab and platinum chemotherapy, for the initial treatment of patients with metastatic non-squamous non-small cell lung cancer (NSCLC), with no EGFR or ALK genomic tumor aberrations. ( 1.1 ) in combination with cisplatin for the initial treatment of patients with locally advanced or metastatic, non-squamous NSCLC. ( 1.1 ) as a single agent for the maintenance treatment of patients with locally advanced or metastatic, non-squamous NSCLC whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. ( 1.1 ) as a single agent for the treatment of patients with recurrent, metasta…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 021462

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 021462
Product	Strength	Form · route	Labeler	Product NDC
Alimtapemetrexed disodium	Pemetrexed disodium heptahydrate 100 mg/4mL	Injection, Powder, Lyophilized, For solutionIntravenous	Eli Lilly and Company	0002-7640